Litigation Details for KPH Healthcare Services, Inc. v. Takeda Pharmaceutical Company Ltd. (D. Mass. 2021)
✉ Email this page to a colleague
KPH Healthcare Services, Inc. v. Takeda Pharmaceutical Company Ltd. (D. Mass. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-08-03 |
| Court | District Court, D. Massachusetts | Date Terminated | 2023-01-24 |
| Cause | 15:1 Antitrust Litigation | Assigned To | |
| Jury Demand | Plaintiff | Referred To | |
| Parties | TAKEDA PHARMACEUTICALS U.S.A., INC. | ||
| Patents | 6,414,016; 6,583,174; 6,982,283; 7,064,148; 7,417,067; 7,795,312; 8,026,393; 8,071,613; 8,088,934; 8,097,649; 8,097,653; 8,114,890; 8,338,639; 8,389,542; 8,748,481; 8,779,187 | ||
| Attorneys | Jessica Rose MacAuley | ||
| Firms | Roberts Law Firm US, PC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in KPH Healthcare Services, Inc. v. Takeda Pharmaceutical Company Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for KPH Healthcare Services, Inc. v. Takeda Pharmaceutical Company Ltd. (D. Mass. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-09-20 | 11 | Amended Complaint | 6,414,016 (the “‘016 patent”); 8,071,613 (the “‘613 patent”); and …developing patent portfolios for their profitable drugs. 25. The first patent or patents in a branded…earlier-obtained patents. These narrower, later- obtained patents reflect, correspondingly, patents that are …challenge patents ostensibly covering the branded drug. A patent infringement lawsuit by the patent holder…The ‘858 patent was the Amitiza drug substance, or compound, patent and the strongest patent in the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
